Nice article28 Apr 2020 22:58
https://www.google.co.uk/amp/s/www.nsmedicaldevices.com/news/uk-covid-19-antibody-testing/amp/
How shortage of Covid-19 antibody testing kits can be eased by collaboration in UK biotech industry
Jamie Bell Jamie Bell
7 hours ago
Attention in the UK biotech industry is turning towards developing antibody tests for Covid-19 (Credit: Pixnio)
At-home testing may be on the horizon
The venture with Mologic is only one half of what Omega is doing to contribute to the UK’s antibody testing capacity.
In what King describes as a “non-Covid world”, these ELISA-based tests are more than suitable for testing patients for certain antibodies. They are cost-effective, and can be analysed in bulk inside a laboratory.
However, with testing being more urgent than ever during this crisis, attention is also turning towards another method of antibody testing, referred to as a lateral flow test.
These kits are similar to a standard pregnancy test, in appearance at least, as they consist of little more than a test stick.
Like the ELISA-based test, they work by analysing a blood sample for antibodies — although they can be used at home by patients, and they don’t need to be sent off to a lab for results because the test stick itself provides a positive or negative reading within minutes.
As part of a biotech consortium with three other UK firms — London-based diagnostic company Abingdon Health, BBI Healthcare and CIGA Healthcare — Omega is working to develop, and ultimately mass produce one of these lateral flow testing kits.
The group is being referred to as the UK Rapid Test Consortium (UK-RTC).